Zydus & Torrent Pharma Partner To Co-Market Semaglutide Injection
18 Mar 2026 //
ECONOMICTIMES
Sentynl Therapeutics Enters into Agreement with PRG S&T
16 Mar 2026 //
PR NEWSWIRE
China`s NMPA Approves Zydus-Licensed Anaemia Drug Desidustat
15 Mar 2026 //
INDPHARMAPOST
Zydus Gets USFDA Nod For Cevimeline HCL Capsules
15 Mar 2026 //
INDPHARMAPOST
Zydus Gets USFDA Nod For Cevimeline HCL Capsules 30Mg
13 Mar 2026 //
EXPRESSPHARMA
Zydus Enhances Companion Diagnostics With AI-Powered CGM Diasens
12 Mar 2026 //
INDPHARMAPOST
Zydus’ Generics Cevimeline HCl Receives Approval in US
11 Mar 2026 //
FDA
Ahead Of Its Time, A GLP-1 Drug Almost Made It Out Of India
04 Mar 2026 //
ECONOMICTIMES
Zydus Gets Final USFDA Nod For Ivermectin Tablets
02 Mar 2026 //
INDPHARMAPOST
Glenmark Set To Join Peers In `Semaglutide` Push
02 Mar 2026 //
ECONOMICTIMES
Zydus` Keytruda Biosimilar Succeeds in FYB206 Trial
28 Feb 2026 //
INDPHARMAPOST
Zydus Launches Semaglutide in India After Patent Expiry
26 Feb 2026 //
EXPRESSPHARMA
Zydus’ Generics Ivermectin Receives Approval in US
26 Feb 2026 //
FDA
Zydus to launch generic semaglutide injections in India
25 Feb 2026 //
ECONOMICTIMES
Semaglutide Patent Expiry Slashes India`s Weight-Loss Drug Prices
25 Feb 2026 //
ECONOMICTIMES
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg
20 Feb 2026 //
EXPRESSPHARMA
Zydus Gets USFDA Nod For Bosentan 32mg Oral Suspension
19 Feb 2026 //
INDPHARMAPOST
Zydus Launches PEPAIR: India`s First Affordable OPEP Device
17 Feb 2026 //
EXPRESSPHARMA
Zydus Gets USFDA Nod For Ammonium Lactate Cream 12%
15 Feb 2026 //
INDPHARMAPOST
Zydus’ Generics Metronidazole Receives Approval in US
13 Feb 2026 //
FDA
Zydus’s Generics Metronidazole Receives Approval in US
13 Feb 2026 //
FDA
Zydus’ Generics Ammonium Lactate Receives Approval in US
12 Feb 2026 //
FDA
Zydus’s Generics Ammonium Lactate Receives Approval in US
12 Feb 2026 //
FDA
SC Clears Zydus to Sell Cancer Drug; BMS Told to Map Patents
11 Feb 2026 //
ECONOMICTIMES
Zydus Gets USFDA Orphan Drug Designation For Desidustat
07 Feb 2026 //
INDPHARMAPOST
Zydus` Desidustat Receives USFDA Orphan Drug Designation
06 Feb 2026 //
EXPRESSPHARMA
Zydus Secures USFDA Orphan Drug Status For Desidustat In Sickle
06 Feb 2026 //
ECONOMICTIMES
Zydus Receives USFDA Tentative Approval For Dapagliflozin Tablets
05 Feb 2026 //
EXPRESSPHARMA
Bristol Myers Halts Zydus` Biosimilar Cancer Drug Sales
29 Jan 2026 //
ECONOMICTIMES
Zydus Lifesciences Introduces First Nivolumab Biosimilar
23 Jan 2026 //
ECONOMICTIMES
Zydus Launches Biosimilar For Treatment Of Multiple Cancers
22 Jan 2026 //
ECONOMICTIMES
Zydus Lifesciences Gets USFDA Nod For Generic Blood Disorder Drug
17 Jan 2026 //
ECONOMICTIMES
Zydus Receives Final Approval From USFDA For Eltrombopag Tablets
16 Jan 2026 //
INDPHARMAPOST
Zydus Lifesciences Completes the Acquisition of Agenus Facility
15 Jan 2026 //
PR NEWSWIRE
Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO
12 Jan 2026 //
PRESS RELEASE
Zydus & Bioeq Partner for US NUFYMCO Launch
23 Dec 2025 //
PR NEWSWIRE
Zydus, Myriad Ink Cancer Test Deal in India
20 Dec 2025 //
INDPHARMAPOST
Sentynl Therapeutics Announces FDA Acceptance Of CUTX-101 NDA
15 Dec 2025 //
PR NEWSWIRE
Sentynl Selects Mytomorrows To Lead Managed Access Program
10 Dec 2025 //
PR NEWSWIRE
Zydus Introduces Cost-Effective Biosimilar `Zyrifa`
10 Dec 2025 //
INDPHARMAPOST
Zydus, Formycon Partner For Exclusive Biosimilar Supply
09 Dec 2025 //
PR NEWSWIRE
Pharma Gains from Rupee`s Fall Despite Reliance on APIs
04 Dec 2025 //
BUSINESS STD
Zydus Gets Tentative FDA Nod For Empagliflozin, Linagliptin
28 Nov 2025 //
EXPRESSPHARMA
Zydus, RK Pharma Strike Exclusive Deal For Novel Oncology
26 Nov 2025 //
PR NEWSWIRE
Zydus Gets FDA Nod For Verapamil Hydrochloride ER Tablets
26 Nov 2025 //
INDPHARMAPOST
Zydus’ Generics Verapamil HCl Receives Approval in US
24 Nov 2025 //
FDA
Zydus Lifesciences Receives USFDA Approval For Leuprolide Acetate
14 Nov 2025 //
ECONOMICTIMES
Zydus Gets FDA Nod For Diroximel Fumarate Capsules
14 Nov 2025 //
INDPHARMAPOST
Zydus Gets Chinese Health Regulator Nod For Generic Anxiety Drug
11 Nov 2025 //
ECONOMICTIMES
Zydus Lifesciences Posts Q2 FY26 PAT At Rs. 1,258.6 Cr
10 Nov 2025 //
INDPHARMAPOST
Zydus Gets FDA Orphan Drug Designation For Desidustat
06 Nov 2025 //
INDPHARMAPOST
Zydus Gets FDA Tentative Approval For 4mg Budesonide Capsules
05 Nov 2025 //
INDPHARMAPOST
FDA Issues Form 483 to Zydus Lidescience
30 Oct 2025 //
FDA
Zydus Gets Health Canada Approval For Mesalamine Suppositories
27 Oct 2025 //
INDPHARMAPOST
DRL, Zydus Recall Drugs In US Over Manufacturing Issues
13 Oct 2025 //
ECONOMICTIMES
Zydus Gets Health Canada Approval For Liothyronine Tablets
07 Oct 2025 //
INDPHARMAPOST
Zydus Lifesciences Gets USFDA Nod For Deflazacort Oral Suspension
06 Oct 2025 //
ECONOMICTIMES
Indian Pharma Alliance appoints Zydus MD Sharvil Patel
04 Oct 2025 //
ECONOMICTIMES
Zydus Lifesciences’s Generics Deflazacort Receives Approval in US
03 Oct 2025 //
FDA
SEC Seek Zydus` Revised Protocol For Ph 1 Chikungunya Vaccine
03 Oct 2025 //
PHARMABIZ

Market Place
Sourcing Support